Does Severity of Neuropathy Influence Consent to Invasive Investigative Procedures in Clinical Trials? Determinants for Sural Nerve Biopsy

Bril, Vera; Kojic, Jasna; Chun, Rosaleen

doi:10.2337/diacare.20.7.1203

Article navigation

Letters| July 01 1997

Does Severity of Neuropathy Influence Consent to Invasive Investigative Procedures in Clinical Trials? Determinants for Sural Nerve Biopsy

Vera Bril, MD;

Vera Bril, MD

General Division of Neurology, Toronto Hospital

Toronto, Ontario, Canada

Search for other works by this author on:

This Site

PubMed

Google Scholar

Jasna Kojic, MD;

Jasna Kojic, MD

General Division of Neurology, Toronto Hospital

Toronto, Ontario, Canada

Search for other works by this author on:

This Site

PubMed

Google Scholar

Rosaleen Chun, MD

General Division of Neurology, Toronto Hospital

Toronto, Ontario, Canada

Search for other works by this author on:

This Site

PubMed

Google Scholar

Address correspondence and reprint requests to Vera Bril, The Toronto Hospital, General Division, Division of Neurology, 200 Elizabeth St., EN 11-209, Toronto, Ontario, M5G 2C4, Canada.

Diabetes Care 1997;20(7):1203–1204

https://doi.org/10.2337/diacare.20.7.1203

PubMed:

9203464

Does Severity of Neuropathy Influence Consent to Invasive Investigative Procedures in Clinical Trials? Determinants for Sural Nerve Biopsy

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Does Severity of Neuropathy Influence Consent to Invasive Investigative Procedures in Clinical Trials? Determinants for Sural Nerve Biopsy

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only